185 related articles for article (PubMed ID: 20449800)
21. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease.
Huerta C; Alvarez V; Mata IF; Coto E; Ribacoba R; Martínez C; Blázquez M; Guisasola LM; Salvador C; Lahoz CH; Peña J
Neurosci Lett; 2004 Nov; 370(2-3):151-4. PubMed ID: 15488313
[TBL] [Abstract][Full Text] [Related]
22. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
23. Association of CCR5-59029 A/G and CCR2-V64I variants with renal allograft survival.
Omrani MD; Mokhtari MR; Tagizadae A; Bagheri M; Ahmad-Poor P
Iran J Immunol; 2008 Dec; 5(4):201-6. PubMed ID: 19098363
[TBL] [Abstract][Full Text] [Related]
24. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients.
Zheng B; Wiklund F; Gharizadeh B; Sadat M; Gambelunghe G; Hallmans G; Dillner J; Wallin KL; Ghaderi M
Anticancer Res; 2006; 26(5B):3669-74. PubMed ID: 17094383
[TBL] [Abstract][Full Text] [Related]
26. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
27. [Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer].
Liu J; Yang XM; Liu G; Chang LS; Zhang LR; Song DK
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3122-5. PubMed ID: 20193274
[TBL] [Abstract][Full Text] [Related]
28. Lack of association between monocyte protein-1 (MCP-1) -2518 A>G chemoattractant and C-C chemokine receptor 2 (CCR2) Val64Ile polymorphisms and multiple sclerosis in a Tunisian population.
Messadi A; Fekih-Mrissa N; Kallel A; Bouguerra C; Sediri Y; Zaweli J; Laayouni S; Nciri B; Yedeas M; Mrissa R; Jemaa R; Kaabachi N; Gritli N
J Clin Neurosci; 2010 Oct; 17(10):1311-3. PubMed ID: 20637631
[TBL] [Abstract][Full Text] [Related]
29. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese.
Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Jiang J; Wang Y; Zhang B; Liu M; Li Y
Chin Med J (Engl); 2001 Nov; 114(11):1162-6. PubMed ID: 11729511
[TBL] [Abstract][Full Text] [Related]
30. Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: a meta-analysis.
Cho YA; Kim J
Cytokine; 2013 Oct; 64(1):213-20. PubMed ID: 23876399
[TBL] [Abstract][Full Text] [Related]
31. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
33. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.
Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD
HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
[TBL] [Abstract][Full Text] [Related]
35. MCP-1 and CCR2 gene variants and the risk for osteoporosis and osteopenia.
Eraltan H; Cacina C; Kahraman OT; Kurt O; Aydogan HY; Uyar M; Can A; Cakmakoğlu B
Genet Test Mol Biomarkers; 2012 Apr; 16(4):229-33. PubMed ID: 22081934
[TBL] [Abstract][Full Text] [Related]
36. Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease.
Gambelunghe G; Ghaderi M; Gharizadeh B; Brozzetti A; Tortoioli C; Del Sindaco P; Sanjeevi CB; Hjelmström P; Sirsjö A; Nyren P; Santeusanio F; Falorni A
Eur J Immunogenet; 2004 Apr; 31(2):73-6. PubMed ID: 15086346
[TBL] [Abstract][Full Text] [Related]
37. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
[TBL] [Abstract][Full Text] [Related]
38. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population.
Hizawa N; Yamaguchi E; Furuya K; Jinushi E; Ito A; Kawakami Y
Am J Respir Crit Care Med; 1999 Jun; 159(6):2021-3. PubMed ID: 10351956
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications.
Yang B; Houlberg K; Millward A; Demaine A
Cytokine; 2004 May; 26(3):114-21. PubMed ID: 15135805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
